# Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.

> **NCT04748445** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 9151 (actual)

## Conditions studied

- Healthy

## Interventions

- **DIAGNOSTIC_TEST:** SARS-CoV-2/Influenza/RSV RT-PCR

## Key facts

- **NCT ID:** NCT04748445
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-12
- **Primary completion:** 2022-04-22
- **Final completion:** 2022-04-22
- **Target enrollment:** 9151 (ACTUAL)
- **Last updated:** 2024-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04748445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04748445, "Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04748445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*